Bioequivalence and Bioavailability Forum 14:30 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Maitri
Junior

India,
2018-09-21 19:49

Posting: # 19297
Views: 335
 

 Reference Scale Average Bioequivalence Approach- ANVISA, Brazil [Regulatives / Guidelines]

Hello,

Can any one comment on acceptability of Reference Scale Bioequivalence Approach for ANVISA ( Regulatory agency of Brazil) for highly variable drugs? Do they accept RSABE study design for Highly variable drug compunds?

Thanks & Regards,
Maitri Sanghavi
d_labes
Hero

Berlin, Germany,
2018-09-22 14:11

@ Maitri
Posting: # 19298
Views: 289
 

 RSABE - ANVISA

Dear Maitri,

» Can any one comment on acceptability of Reference Scale Bioequivalence Approach for ANVISA ( Regulatory agency of Brazil) for highly variable drugs? Do they accept RSABE study design for Highly variable drug compunds?

Have you ever discovered the search field in the upper right corner of the forum?

Use it and you will find some threads dealing with the ANVISA specifications for scaled ABE. E.g. this one.

What do you think: If they have specifications for scaled ABE, do they accept studies using that approach?

Regards,

Detlew
Back to the forum Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
18,761 posts in 3,996 threads, 1,258 registered users;
online 14 (0 registered, 14 guests [including 11 identified bots]).

A drug is that substance which, when injected into a rat,
will produce a scientific report.    Anonymous

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed